<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A21478EA-E506-4B64-A8A9-42CD8D97C635"><gtr:id>A21478EA-E506-4B64-A8A9-42CD8D97C635</gtr:id><gtr:name>University College London Hospital (UCLH) NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/E282559A-3DA1-4897-BFC6-23BDECADEAA8"><gtr:id>E282559A-3DA1-4897-BFC6-23BDECADEAA8</gtr:id><gtr:firstName>Neal</gtr:firstName><gtr:surname>Navani</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800465"><gtr:id>0F102AB4-9273-442D-BB9F-F711F533D18B</gtr:id><gtr:title>BOOST: Bronchoscopic or oesophageal ultrasound as a first test for the diagnosis and staging of lung cancer</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0800465</gtr:grantReference><gtr:abstractText>The best treatment for lung cancer is surgery. However, if disease has spread outside the lung then surgery is not recommended and therefore determining whether lung cancer has spread is a critical step in management.

Unfortunately in 80% of lung cancer cases, the disease will have already spread outside the lungs. The most common place that the disease first spreads to, is glands in the chest between the lungs (mediastinum). Currently, however, assessment of the mediastinum requires several scans and often an operation. This is time consuming, expensive, technically difficult and often inaccurate.

A new diagnostic technology called endoscopic ultrasound uses sound waves to look through the walls of the airways or oesophagus (gullet), enabling direct visualisation and sampling of the mediastinum as a day-case procedure. Sampling the mediastinum provides information on the type of lung cancer and whether it has spread in one investigation. We believe endoscopic ultrasound should be a first diagnostic investigation (after a CT scan) in patients referred with suspected lung cancer. We envisage that this will be more accurate, take less time and by preventing other scans and operations will represent significant cost savings. This improved patient pathway can be implemented in cancer centres around the country.</gtr:abstractText><gtr:technicalSummary>BOOST: Bronchoscopic or Oesophageal ultrasound for lung cancer staging
A randomised controlled trial of endobronchial ultrasound or endoscopic ultrasound as a first test in the diagnosis and staging of non-small cell lung cancer

Background
Lung cancer is the leading cause of cancer death in the UK. The staging of lung cancer is a critical step which determines treatment options but currently it requires an average of 45 days, is expensive and inaccurate. 90% of lung cancer patients in the UK have inoperable cancer. Therefore establishing the diagnosis and the presence of metastatic spread with a single test would shorten the patient journey and reduce the need for expensive further tests, such as PET and mediastinoscopy. Having a first line test that diagnoses mediastinal metastasis with accuracy may also reduce inappropriate operations where current techniques fail to confirm tumour spread.

Hypothesis
EUS (endoscopic ultrasound) or EBUS-FNA (endobronchial ultrasound guided fine needle aspiration) as a first test after CT scan in the diagnosis and staging of lung cancer will result in a reduction in the time from first outpatient appointment to treatment, a reduction in the number of PET scans, mediastinoscopies and futile thoracotomies and lower NHS healthcare costs.

Methods
Study Design
Baseline data will be collected from 200 retrospective patients from 5 North London Cancer Network Hospitals in order to confirm current practice. Prospective data will be collected from consecutive patients suspected of lung cancer in 3 centres. Patients with extra-thoracic disease amenable to biopsy or pleural effusions are excluded. The remaining patients are randomised to control or active arms. The control arm will consist of 84 patients being managed according to local clinical practice. Eighty-four patients in the active arm will undergo EUS or EBUS-FNA as a first test after CT scan.
Endpoints
The primary endpoint is the number of days from first outpatient appointment to treatment start. 
The secondary endpoints are:
i. The healthcare costs of diagnosing and staging lung cancer
ii. The number of tests and outpatient visits a patient requires to be diagnosed and staged with lung cancer
iii. The proportion of lung cancer patients that are diagnosed and staged with a single test after CT scan
iv. The number of futile thoracotomies

By demonstrating that EBUS/EUS as a first test after CT scan is effective in diagnosing and staging lung cancer, we believe, will result in a change in the staging algorithm for lung cancer.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>221436</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Influence on NICE and British Throacic Society Guidance</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>NICE Lung Cancer 2011, BTS bronchoscopy guideline</gtr:guidelineTitle><gtr:id>10FE09BC-5B68-4DE1-90B4-1D2C3FB08BAE</gtr:id><gtr:impact>The work from the MRC fellowship has established EBUS-TBNA as an important new investigation for patient siwth respiratory disease and is now in routine clinical use.</gtr:impact><gtr:outcomeId>o2W9g8G5MXD</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>2369F3CE-C551-4F06-8490-DB8F294493EA</gtr:id><gtr:title>Preoperative integrated PET-CT scanning reduces the number of futile thoracotomies for lung cancer.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>4FD8D261301</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A1EA5611-B016-4697-B3B3-8F7D68F814CD</gtr:id><gtr:title>Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13736_26_22652031</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>42D042EE-1929-42AB-BE72-B7A7B4BA872C</gtr:id><gtr:title>Endobronchial ultrasound-guided transbronchial needle aspiration for lymphoma: the final frontier.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>58c7e048976085.87846816</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8B35C24-3F4A-4BB3-A948-7E39E5240721</gtr:id><gtr:title>Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial.</gtr:title><gtr:parentPublicationTitle>The Lancet. Respiratory medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2213-2600</gtr:issn><gtr:outcomeId>58c7e0483d86d0.62938180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>20932A2B-7F44-4BC5-A6F0-502B8F7AE363</gtr:id><gtr:title>Impact of EBUS-TBNA on modalities for tissue acquisition in patients with lung cancer.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fcb2b2ae2b48420e2e06b876baea5479"><gtr:id>fcb2b2ae2b48420e2e06b876baea5479</gtr:id><gtr:otherNames>Jos? RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>58c7e048e98ab7.46204706</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF81779A-DB3C-45CE-92DC-B62FF5308A9E</gtr:id><gtr:title>Induction chemotherapy and continuous hyperfractionated accelerated radiotherapy (chart) for patients with locally advanced inoperable non-small-cell lung cancer: the MRC INCH randomized trial.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a0fb6b7cf792c26109b42a4833bf67e"><gtr:id>5a0fb6b7cf792c26109b42a4833bf67e</gtr:id><gtr:otherNames>Hatton M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn><gtr:outcomeId>fzLk1V31U1p</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ED81C721-93B1-4E6B-9348-96F52064F783</gtr:id><gtr:title>Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non-Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials.</gtr:title><gtr:parentPublicationTitle>Clinical lung cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21f668352004702303f2e8e0e2b26d93"><gtr:id>21f668352004702303f2e8e0e2b26d93</gtr:id><gtr:otherNames>Vale CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1525-7304</gtr:issn><gtr:outcomeId>58c7e048745927.85616852</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD6907B8-C792-40E6-A650-A71D5B0440B0</gtr:id><gtr:title>Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of intrathoracic lymphadenopathy in patients with extrathoracic malignancy: a multicenter study.</gtr:title><gtr:parentPublicationTitle>Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1556-0864</gtr:issn><gtr:outcomeId>EmvMM2DE8oJ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEE04D69-424F-4434-AE55-BABE1CC5990C</gtr:id><gtr:title>Reply: Optimum performance of endobronchial ultrasound-guided transbronchial needle aspiration.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13736_26_24180446</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31A62DBB-5AE2-4E28-8DB2-A9C7CFD9160D</gtr:id><gtr:title>Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>UyTQavPrJcn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A77B4CF7-DED3-484C-ABFB-1BD84D35C112</gtr:id><gtr:title>EBUS-TBNA for the mediastinal staging of non-small cell lung cancer.</gtr:title><gtr:parentPublicationTitle>Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1556-0864</gtr:issn><gtr:outcomeId>ADA459BB1E4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86B72F58-5F31-4CAA-BA4F-8C79FC8FC2C2</gtr:id><gtr:title>A rare asthma mimic exposed by basic physiology.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>tSbKaJCTSSk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3CD2142-C1AF-4512-8E10-1D6D0551DA22</gtr:id><gtr:title>Reply: lung cancer diagnosis and staging centers.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13736_26_23536936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>007191C8-0CA2-47A8-8F2B-13A27559A1C9</gtr:id><gtr:title>Lung cancer staging with minimally invasive endoscopic techniques.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>AB873ABCFD7</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8687C613-EA4F-4A96-9096-04FE6234DF04</gtr:id><gtr:title>Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64623a275fcc8afde5c9d18bb794cebc"><gtr:id>64623a275fcc8afde5c9d18bb794cebc</gtr:id><gtr:otherNames>Loebinger MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>B3377415246</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>389CAE00-282E-4AB8-971D-08C855F9FB68</gtr:id><gtr:title>Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13736_26_22505743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F078AA9A-690A-4820-A5EC-62CF2B1AB821</gtr:id><gtr:title>Interim data from the Medical Research Council QUARTZ Trial: does whole brain radiotherapy affect the survival and quality of life of patients with brain metastases from non-small cell lung cancer?</gtr:title><gtr:parentPublicationTitle>Clinical oncology (Royal College of Radiologists (Great Britain))</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2a71af17ab23169ccaa01135ba3297c2"><gtr:id>2a71af17ab23169ccaa01135ba3297c2</gtr:id><gtr:otherNames>Langley RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0936-6555</gtr:issn><gtr:outcomeId>pm_13736_26_23211715</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D705FBC8-117B-4172-9405-331881695561</gtr:id><gtr:title>Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Clinical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1759-4774</gtr:issn><gtr:outcomeId>C0D37441C9A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD12A7C9-3AFD-40B7-AA29-7C7CC798EB43</gtr:id><gtr:title>Pulmonary mass in a 19-year-old male. Inflammatory myofibroblastic tumour.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b5320bba7f2766a860341f917c99dc58"><gtr:id>b5320bba7f2766a860341f917c99dc58</gtr:id><gtr:otherNames>Smith LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>pm_13736_26_22106020</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B901DAE-5CFC-4B83-94CC-2320DC105FB1</gtr:id><gtr:title>Pleuro-cutaneous fistula complicating chest drain insertion for tuberculous effusion.</gtr:title><gtr:parentPublicationTitle>QJM : monthly journal of the Association of Physicians</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1460-2393</gtr:issn><gtr:outcomeId>1B540F17562</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>49E63F3A-4978-4536-BBA7-3BD9BC839D18</gtr:id><gtr:title>Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>rAV8tEipPRC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E89BFF5-E108-4423-B04E-11E3472210AF</gtr:id><gtr:title>PET scanning is important in lung cancer; but it has its limitations.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>NZ1dJYn5wkN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45DA5E05-2031-4993-81C0-C03B8786BFFC</gtr:id><gtr:title>Screening for lung cancer: is this the way forward?</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00c1f7451fabfc732c6054480a10727f"><gtr:id>00c1f7451fabfc732c6054480a10727f</gtr:id><gtr:otherNames>Spiro SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>pm_13736_26_22142440</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3614F4F7-2244-4A3A-A5D6-D4AA7D827129</gtr:id><gtr:title>Combination of endobronchial ultrasound-guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and stage II pulmonary sarcoidosis.</gtr:title><gtr:parentPublicationTitle>Respirology (Carlton, Vic.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1323-7799</gtr:issn><gtr:outcomeId>Y6uHJJowuSS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1386D78B-B9BF-47BA-8364-851AB5C6A060</gtr:id><gtr:title>EBUS-TBNA with ROSE-tinted spectacles?</gtr:title><gtr:parentPublicationTitle>Respiration; international review of thoracic diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1c42373c4b4f500af67b10708441049e"><gtr:id>1c42373c4b4f500af67b10708441049e</gtr:id><gtr:otherNames>Hardavella G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0025-7931</gtr:issn><gtr:outcomeId>pm_13736_26_24192324</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70F1057B-4BC6-4FEC-A5EE-75270FE3ED6A</gtr:id><gtr:title>The learning curve for EBUS-TBNA.</gtr:title><gtr:parentPublicationTitle>Thorax</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0040-6376</gtr:issn><gtr:outcomeId>tZa2UvVxZ7D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D92B464-40AF-4F10-95AA-49F075EA5522</gtr:id><gtr:title>Reply: endobronchial ultrasound-guided transbronchial needle aspiration versus cervical mediastinoscopy: case selection is needed to maintain clinical as well as cost benefits.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ac58f8d0ee40842b1e7e0ef017575a6"><gtr:id>3ac58f8d0ee40842b1e7e0ef017575a6</gtr:id><gtr:otherNames>Navani N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>pm_13736_26_23536935</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800465</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>